Jul 2026· International Journal of Innovative Science and Research Technology· pp. 269· 0 citations· 37 references
TL;DR
A transparent, human-centered methodology for comparing autism diagnosis systems without overstating causal claims is presented, and policy implications focus on early screening, workforce development, culturally valid tools, telehealth, data infrastructure, and ethically governed AI systems for low-resource settings.
Abstract
This article presents a refined empirical framework for studying global disparities in autism spectrum disorder
(ASD) diagnosis and service access across the United States, selected African countries, and high-income comparator
countries. Unlike earlier drafts that treated the subject as a generic macroeconomic panel problem, the present manuscript
is aligned with the accompanying data workbook, which identifies concrete sources for country-level ASD prevalence and
burden estimates, U.S. Autism and Developmental Disabilities Monitoring (ADDM) Network surveillance measures, World
Bank development indicators, WHO policy benchmarks, and optional clinical imaging data from ABIDE. The paper is
written as a reproducible data-driven study rather than a claim of completed causal estimation: where the workbook
provides templates rather than populated country-year values, the text distinguishes actual data sources from proposed
estimands. The conceptual argument is that observed autism prevalence is not only a neurodevelopmental measure; it is also
shaped by diagnostic infrastructure, clinical workforce capacity, school-based screening, insurance coverage, social
awareness, stigma, income, and digital readiness. The proposed analytical design combines descriptive inequality indices,
multilevel regression, Oaxaca–Blinder decomposition, random forest, gradient boosting, and SHAP-based explainability to
identify the predictors most associated with cross-national differences in autism identification. The central contribution is a
transparent, human-centered methodology for comparing autism diagnosis systems without overstating causal claims. The
article emphasizes that lower reported prevalence in many African countries should not be interpreted as lower underlying
need, because underdiagnosis, late identification, and limited surveillance capacity remain central measurement challenges.
Policy implications focus on early screening, workforce development, culturally valid tools, telehealth, data infrastructure,
and ethically governed AI systems for low-resource settings.
It is argued that AI’s most important contribution to autism care is unlikely to lie in marginal improvements in classification accuracy alone, and its potential value lies in expanding access, supporting task-sharing, shortening diagnostic pathways, enabling population-oriented screening, and reaching under-recognised groups.
Xugao Han, Lingyan Weng, Houxi Xu· Frontiers in Public Health· 0 citations
Introduction Artificial intelligence (AI)-supported tools may shorten autism spectrum disorder (ASD) identification pathways, but their public health value depends on whether earlier identification is followed by timely intervention. Methods This study developed a calibrated, scenario-based cost-of-illness model to examine how AI-supported early autism identification could affect the timing and magnitude of US societal ASD-related costs under explicitly stated assumptions. The model reconstructed a business-as-usual baseline from 2011 cost cells, calibrated annual per-person cost growth to reproduce a published 2025 national burden benchmark of approximately $461 billion, and projected costs from 2025 to 2050 using a cohort-based stock model. AI-supported tools were represented as accelerators within screening, triage, referral, and clinician-led diagnostic pathways. Results Under the Base deployment scenario, cumulative discounted net cost remained positive through 2050 at approximately $52 billion, while annual net costs declined sharply toward zero. The High deployment scenario reached annual net savings by the mid-2040s. Extended-horizon analysis indicated that cumulative fiscal payback may emerge after the primary 25-year policy window. Prevalence, per-person cost growth, and population growth mainly scaled national dollar totals; discounting changed the present value assigned to delayed savings; and the adult trajectory-shift assumption strongly influenced payback timing. Discussion These findings are conditional projections, not estimates of realized savings from observed AI deployment. Their interpretation depends on timely intervention access, adequate service capacity, equitable implementation, and durable reductions in downstream support needs. Calibration provides a transparent published baseline for scenario analysis; it does not validate future projections.
Tannista Banerjee, A. Nayak· Frontiers in Public Health· 0 citations
BACKGROUND
Since the 1990s, rates of autism spectrum disorder (henceforth 'autism') diagnosis have increased dramatically. To understand if this growth is ongoing, and to understand the changing profile and needs of those with an autism diagnosis, we investigated time trends (2016-2024) in: (a) the number and proportion of UK school pupils identified as autistic; and (b) the characteristics of these autistic pupils, in terms of their age, sex, ethnicity, socio-economic position and co-occurring needs.
METHODS
The study used annual data from the School Census (2016-2024) in England, covering 8-8.5 million pupils in each census year. Autism was identified as a pupil having a recorded autism-specific special educational need or disability (SEND).
RESULTS
The prevalence of identified autism grew rapidly, from 1.5% in 2016 to 3.3% in 2024. During this time, the male-to-female ratio of autistic pupils fell from 4.9-to-1 to 2.8-to-1, and the proportion of autistic pupils with an identified intellectual disability fell from 15.1% to 8.7%. Across the study timeframe, autistic pupils were more likely to be White British and from an economically deprived background. We found evidence of 'locked in' future increases in prevalence from the movement of cohorts up the school system.
CONCLUSIONS
As indexed by SEND data, rates of autism diagnosis in England continue to grow, in part driven by greater recognition of girls and those without intellectual disability. These findings highlight the need for forward planning to meet the growth and evolving profile of people with autism-related needs, in education and beyond.
David Frayman, W. Mandy· Journal of Child Psychology...· 0 citations
This narrative literature review synthesizes evidence on social, medical, and structural barriers affecting children with ASD, with a focus on healthcare access, comorbidity-related medical vulnerability, and public stigma in Kazakhstan and internationally.
Svetlana Mofa, Bauyrzhan Omarkulov, N. Delellis et al.· Journal of Clinical Medicine...· 0 citations
This manuscript proposes reframing the “autism spectrum” from a hierarchy of symptom severity to a prevention-oriented “spectrum of care” that aligns autism services with whole-child, neurodiversity-affirming, and developmentally informed care, emphasizing relational health, autonomy, and life-course participation.
Steven Merahn· Frontiers in child and adole...· 1 citation
Machine learning can support diagnosticians in this effort, as demonstrated here utilizing multiple rating scales, the TASI, and the TAP, but there is a risk for bias when using machine learning and as such, no algorithm should replace expert clinical judgment.
Aaron J. Kaat, Ashlynn Campagna, Hannah Feiner et al.· JCPP Advances· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.